Hence, our current study involved a systematic review and pooled analyses of the literature to reveal possible correlations between the irAEs induced by PD-1 blockade and favorable clinical outcomes in patients with NSCLC. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.